Patents by Inventor Charles Stiles

Charles Stiles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SHIPPING CONTAINER AND METHOD OF FORMING AND USING SAME
    Publication number: 20090188820
    Abstract: A container configured to protect items during shipping and storage is disclosed. The container includes a cover, a liner, and an inflatable bladder between the liner and the cover. The container further includes a protective plate, which optionally houses one or more pumps to inflate the bladder. The container may also include a retractable handle, which may form part of the pump.
    Type: Application
    Filed: January 25, 2008
    Publication date: July 30, 2009
    Inventors: Daniel McGrail, David Sanches, Charles Stiles
  • INFLATABLE SHIPPING DEVICE AND METHOD OF FORMING AND USING SAME
    Publication number: 20060185998
    Abstract: An assembly, carrier, and method configured to protect items during shipping and storage is disclosed. The assembly includes inflatable cells to protect the items. The assembly may also include additional protective layers to prevent puncture of the cells.
    Type: Application
    Filed: January 30, 2006
    Publication date: August 24, 2006
    Inventors: Daniel McGrail, David Sanches, Charles Stiles
  • Methods and compositions for treating hyperproliferative conditions
    Publication number: 20050215564
    Abstract: The present invention relates to a combination which comprises (a) an inhibitor of a tissue non-specific growth factor receptor and (b) an inhibitor of a tissue specific growth factor receptor for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of hyperproliferative conditions, such as in particular cancer, in a mammal, particularly a human. The invention also relates to pharmaceutical compositions comprising such a combination and to a method of treating hyperproliferative conditions, such as especially cancer, with such a combination. The present invention further also relates to a commercial package or product comprising such a combination.
    Type: Application
    Filed: February 14, 2002
    Publication date: September 29, 2005
    Inventors: Charles Stiles, Carlos Garcia-Echeverria
  • Suppressing tumor formation using cells expressing JE/monocyte chemoattractant protein-1
    Patent number: 6767535
    Abstract: A method of suppressing tumor formation in a vertebrate by administering JE/MCP-1 is described. Also described are methods of treating localized complications of malignancies and methods of combatting parasitic infection by administering JE/MCP-1.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: July 27, 2004
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Barrett Rollins, Charles Stiles
  • Genetic selection method for identifying ligands for transmembrane proteins
    Patent number: 6420529
    Abstract: A chimeric protein having an (a) IRE1 or analog cytoplasmic kinase domain, (b) a transmembrane domain, and (c) a ligand binding domain of a transmembrane protein other than IRE1 is described. This protein can be used to identify and/or screen for ligands and other molecules that interact with the ligand binding domain.
    Type: Grant
    Filed: March 5, 1998
    Date of Patent: July 16, 2002
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Pamela Silver, Tom Roberts, Charles Stiles
  • Human cytokine
    Patent number: 5278287
    Abstract: A novel human cytokine, JE factor, and processes for producing it are disclosed. JE may be used in pharmaceutical preparations for stimulating and/or enhancing immune responsiveness and in wound healing and related tissue repair. containing the factor.
    Type: Grant
    Filed: April 13, 1993
    Date of Patent: January 11, 1994
    Assignees: Genetics Institute, Inc., Dana-Farber Cancer Institute
    Inventors: Barrett Rollins, Charles Stiles, Gordon G. Wong
  • Process for producing human JE cytokine
    Patent number: 5212073
    Abstract: A novel human cytokine, JE factor, and processes for producing it are disclosed. JE may be used in pharmaceutical preparations for stimulating and/or enhancing immune responsiveness and in wound healing and related tissue repair.
    Type: Grant
    Filed: May 12, 1989
    Date of Patent: May 18, 1993
    Assignees: Genetics Institute, Inc., Dana Farber Cancer Inst.
    Inventors: Barrett Rollins, Charles Stiles, Gordon G. Wong
  • Method of suppressing tumor formation in vivo
    Patent number: 5179078
    Abstract: A method of suppressing tumor formation in a vertebrate by administering JE/MCP-1 is described. Also described are methods of treating localized complications of malignancies and methods of combatting parasitic infection by administering JE/MCP-1.
    Type: Grant
    Filed: May 16, 1991
    Date of Patent: January 12, 1993
    Assignee: Dana Farber Cancer Institute
    Inventors: Barrett Rollins, Charles Stiles